News Ipsen’s Kayfanda (Odevixibat) Gains the CHMP’s Positive Opinion to Treat Cholestatic Pruritus in Alagille Syndrome (ALGS) ByDipanshu DixitJuly 27, 20240Comments
THOUGHTSPOT Managing Chronic Conditions: Medication, Supplements, and Personalized Care PlansByIgor ZagradaninJuly 26, 20240Comments
News Fresenius Kabi and Formycon Report the CHMP’s Positive Opinion of FYB202 (Biosimilar, Stelara) ByDipanshu DixitJuly 26, 20240Comments
News Junshi Biosciences Reports the CHMP’s Positive Opinion of Loqtorzi (Toripalimab) Across Two Indications ByDipanshu DixitJuly 26, 20240Comments
News Ipsen’s Iqirvo (Elafibranor) Gains the CHMP’s Positive Opinion for Treating Primary Biliary Cholangitis (PBC) ByDipanshu DixitJuly 26, 20240Comments
News Johnson & Johnson’s Yuvanci (macitentan and tadalafil) Receives the CHMP’s Positive Opinion for Treating Pulmonary Arterial Hypertension (PAH) ByDipanshu DixitJuly 26, 20240Comments
EVENTS 6 Years of PharmaShots: Epitomising Branding and InsightsBySaurabh ChaubeyJuly 25, 20240Comments
News Bio-Thera Solutions Reports the Initiation of Combined P-I/P-III Study of BAT3306 (Biosimilar, Keytruda)ByDipanshu DixitJuly 25, 20240Comments
